West-China Transfusion Score for Critically-ill Patients
1 other identifier
interventional
100
1 country
1
Brief Summary
Guidelines for blood transfusion have been issued for years. According to these guidelines, red blood cells (RBCs) transfusion should be given when the hemoglobin level is less than 6g/dL or 7g/dL and is unnecessary when the level is more than 10g/dL. However, in all the guidelines, the determination of whether RBCs should be administered when the hemoglobin level is in the range of 6\~10g/dL is based on the judgment from doctors. Index of transfusion trigger for patients with hemoglobin level between 6g/dL and 10g/dL is necessary and important in clinical practice. Based on the aim of blood transfusion that maintain the balance of oxygen supply and oxygen consumption, the investigators hypothesize that index of transfusion trigger for patients with hemoglobin level between 6g/dL and 10g/dL could be calculated by parameters including infusion rate of inotropic drugs for maintaining normal cardiac output, fraction of inspired oxygen, core temperature, and torlerance to anemia. To verify this hypothesis, the investigators present West China Transfusion Score for Critically-ill Patients(WCTS-CP) for the trigger of transfusion according to the patient's history and monitoring parameters, and the investigators design a randomized controlled clinical trial to test this score.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started May 2014
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 11, 2014
CompletedFirst Posted
Study publicly available on registry
May 16, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedMay 16, 2014
May 1, 2014
4 months
May 11, 2014
May 13, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of death and serious complications
28 days
Secondary Outcomes (3)
Transfusion rate and transfusion volume of red blood cells
28 days
ventilator-free days in 28 days
28 days
length of stay in ICU or in hospital
28 days
Study Arms (2)
Transfusion trigger based on WCTS-CP
EXPERIMENTALDetermination of whether a patient need red blood cells transfusion or which hemoglobin level should be maintained is based on WCTS-CP
Transfusion trigger based on experience
ACTIVE COMPARATORDetermination of whether a patient need red blood cell transfusion or which hemoglobin level should be maintained is base on the physician's experience
Interventions
transfusion trigger for experimental group is the WCTS-CP;for active comparator is the physician's experience
Eligibility Criteria
You may qualify if:
- Height of usual place of residence less than 2,500 metres above sea level
- Hemoglobin level possibly less than 10g/dL
You may not qualify if:
- Pregnant women
- Age less than 18
- Serious blood system diseases
- Dysfunction of hemoglobin
- Tumor metastasis
- Psychopathy
- Refuse to sign consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
West China Hospital
Chengdu, Sichuan, 610041, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jin Liu, M.D
West China Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- ICU
Study Record Dates
First Submitted
May 11, 2014
First Posted
May 16, 2014
Study Start
May 1, 2014
Primary Completion
September 1, 2014
Study Completion
December 1, 2014
Last Updated
May 16, 2014
Record last verified: 2014-05